Bayer Aktiengesellschaft (BAYRY) News Today $7.60 +0.15 (+2.01%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock BAYRY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat dealAugust 12 at 4:02 AM | reuters.comBayer, Kumquat Biosciences Team Up on New Potential Cancer DrugAugust 12 at 3:11 AM | wsj.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Upgraded to Buy at Wall Street ZenAugust 11 at 4:26 PM | marketbeat.comBayer AG’s Observational Study on Hemophilia A Treatment: A Market InsightAugust 9 at 8:45 PM | theglobeandmail.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Releases Earnings Results, Beats Expectations By $0.10 EPSAugust 9 at 7:27 AM | marketbeat.comBayer’s Asundexian Study: A Potential Game-Changer in Stroke PreventionAugust 8, 2025 | tipranks.comBayer’s Aficamten Study: A New Hope for oHCM TreatmentAugust 8, 2025 | tipranks.comBayer AG’s Observational Study on Vericiguat: Real-World Insights into Heart Failure TreatmentAugust 8, 2025 | tipranks.comGoldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)August 8, 2025 | theglobeandmail.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 9.2% - Here's What HappenedAugust 7, 2025 | marketbeat.comQ2 2025 Bayer AG Earnings Call TranscriptAugust 6, 2025 | gurufocus.comBayer AG’s New Study on Vericiguat: A Potential Game-Changer for Heart Failure TreatmentAugust 6, 2025 | tipranks.comBAYRY - Bayer AG ADR Chart | MorningstarAugust 6, 2025 | morningstar.comMBayer says it has cut 12,000 jobs so far under restructuring pushAugust 6, 2025 | reuters.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Large Volume Increase - Time to Buy?August 5, 2025 | marketbeat.comBayer Stock Is Soaring Ahead Of Its Earnings ReleaseAugust 5, 2025 | seekingalpha.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 134.5% in JulyAugust 5, 2025 | marketbeat.comBayer’s New Study on Sevabertinib: A Potential Game-Changer for Cancer Patients with Liver ImpairmentAugust 4, 2025 | tipranks.comBayer Aktiengesellschaft (BAYRY) Projected to Post Earnings on TuesdayAugust 4, 2025 | americanbankingnews.comKepler Capital Remains a Buy on Bayer (0P6S)August 3, 2025 | theglobeandmail.comBernstein Keeps Their Hold Rating on Bayer (0P6S)August 2, 2025 | theglobeandmail.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Up - Here's What HappenedAugust 2, 2025 | marketbeat.comBayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney HealthAugust 1, 2025 | tipranks.comBayer’s Observational Study on Darolutamide: Real-World Insights for Prostate Cancer TreatmentAugust 1, 2025 | tipranks.comBayer shares rise after Q2 earnings beat, guidance raised despite litigation hitAugust 1, 2025 | investing.comBayer increases Roundup litigation provisions by $1.37 billionJuly 31, 2025 | reuters.comFrench court finds complaint brought by family in Bayer glyphosate case inadmissible, media saysJuly 31, 2025 | reuters.comBayer’s Hemophilia A Drug Undergoes Key Safety Study in KoreaJuly 30, 2025 | tipranks.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Large Volume Increase - Should You Buy?July 29, 2025 | marketbeat.comBayer Aktiengesellschaft (BAYRY) to Release Earnings on TuesdayJuly 29, 2025 | marketbeat.comBayer’s New Prostate Cancer Study: A Potential Game-Changer?July 28, 2025 | tipranks.comBayer’s Darolutamide Study in India: A Potential Game-Changer for Prostate Cancer TreatmentJuly 28, 2025 | tipranks.comBayer’s New Study on Nifurtimox: Implications for InvestorsJuly 28, 2025 | tipranks.comBayer’s OASIS STAR Study: A New Look at Menopausal Treatment PatternsJuly 28, 2025 | tipranks.comBayer AG’s Clinical Study on BAY94-9027: A Potential Game-Changer for Hemophilia A Treatment in ChildrenJuly 28, 2025 | tipranks.comBayer’s Vilaprisan Study Termination: Implications for InvestorsJuly 28, 2025 | tipranks.comBayer’s Clinical Study Update: A Potential Breakthrough for Pulmonary Hypertension TreatmentJuly 28, 2025 | tipranks.comBayer’s Vericiguat Study: A Potential Game-Changer for Chronic Heart Failure TreatmentJuly 28, 2025 | tipranks.comBayer’s Observational Study on Vericiguat: Insights for InvestorsJuly 28, 2025 | tipranks.comBayer’s Real-World Study on Vericiguat: Market Implications for Heart Failure TreatmentJuly 28, 2025 | tipranks.comBayer AG’s New Study on Menopause and Sleep: A Potential Market Game-ChangerJuly 28, 2025 | tipranks.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Cut to "Hold" at Wall Street ZenJuly 27, 2025 | marketbeat.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 52-Week High - Still a Buy?July 25, 2025 | marketbeat.comUS FDA extends review of Bayer's menopause relief drugJuly 25, 2025 | reuters.comBayer AG’s Exploratory Study on Sepsis and DIC: A Potential Game-Changer?July 25, 2025 | tipranks.comBayer’s Molidustat Study: A Potential Game-Changer for Renal Anemia Treatment?July 25, 2025 | tipranks.comBayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to MenopauseJuly 25, 2025 | businesswire.comBayer AG’s New Study on Sepsis Progression: A Potential Game-Changer?July 23, 2025 | tipranks.comBayer’s Molidustat Study: A Potential Game-Changer for Renal Anemia Treatment?July 23, 2025 | tipranks.comBayer AG’s New Study on Finerenone: A Potential Game-Changer for CKD and T2D Treatment in IndiaJuly 22, 2025 | theglobeandmail.com Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address BAYRY Media Mentions By Week BAYRY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BAYRY News Sentiment▼0.350.75▲Average Medical News Sentiment BAYRY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BAYRY Articles This Week▼178▲BAYRY Articles Average Week Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sanofi News Today Innoviva News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Roche News Today Novartis News Today Novo Nordisk A/S News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BAYRY) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access